Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Arrowhead Pharmaceuticals - 27 Year Stock Price History | ARWR

Historical daily share price chart and data for Arrowhead Pharmaceuticals since 1997 adjusted for splits and dividends. The latest closing stock price for Arrowhead Pharmaceuticals as of April 30, 2024 is 22.62.
  • The all-time high Arrowhead Pharmaceuticals stock closing price was 162.50 on June 09, 2000.
  • The Arrowhead Pharmaceuticals 52-week high stock price is 42.48, which is 87.8% above the current share price.
  • The Arrowhead Pharmaceuticals 52-week low stock price is 20.67, which is 8.6% below the current share price.
  • The average Arrowhead Pharmaceuticals stock price for the last 52 weeks is 30.33.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Arrowhead Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 29.9736 31.0100 39.4800 21.8700 22.6200 -26.08%
2023 30.7630 38.5100 41.3800 21.2000 30.6000 -24.56%
2022 40.1287 69.9700 69.9700 27.7900 40.5600 -38.82%
2021 71.2901 74.8300 90.4700 58.0900 66.3000 -13.59%
2020 45.7652 63.1200 85.3700 20.5600 76.7300 20.97%
2019 29.5977 13.1200 73.0100 12.0500 63.4300 410.71%
2018 11.4308 3.7200 20.3000 3.7200 12.4200 237.50%
2017 2.4264 1.6800 4.5000 1.4400 3.6800 137.42%
2016 5.1806 5.9800 8.0800 1.2400 1.5500 -74.80%
2015 6.4723 7.7100 9.0600 4.9000 6.1500 -16.67%
2014 12.7270 10.3100 26.5700 5.0000 7.3800 -31.98%
2013 4.0250 2.1000 11.0700 1.6900 10.8500 407.01%
2012 3.8995 4.1300 7.1400 2.0100 2.1400 -48.93%
2011 5.8726 10.0000 10.0000 3.5870 4.1900 -53.18%
2010 9.9126 5.4000 18.5000 5.1000 8.9500 68.87%
2009 5.7014 10.5000 12.0000 3.1270 5.3000 -42.39%
2008 21.0717 35.5000 35.5000 7.6750 9.2000 -75.66%
2007 48.5855 44.0000 76.0000 33.6000 37.8000 -13.70%
2006 50.3614 40.4000 76.5000 40.4000 43.8000 3.06%
2005 33.0205 40.0000 52.5000 21.4000 42.5000 -1.62%
2004 51.1342 19.5000 84.0000 19.5000 43.2000 232.31%
2003 8.9559 6.5000 26.0260 3.2500 13.0000 100.00%
2002 13.7847 13.0000 52.0520 1.9500 6.5000 -50.00%
2001 24.8992 39.0000 45.5000 13.0000 13.0000 -66.67%
2000 96.6880 39.0000 162.5000 35.7825 39.0000 0.00%
1999 45.1131 52.0000 97.5000 32.5000 39.0000 -25.00%
1998 37.7619 32.5000 78.0000 26.0000 52.0000 60.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.741B $0.241B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.455B 29.78
Chugai Pharmaceutical (CHGCY) Japan $50.600B 22.62
Takeda Pharmaceutical (TAK) Japan $41.238B 6.68
Merck (MKGAF) Germany $20.301B 19.16
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Sandoz Group AG (SDZNY) Switzerland $14.137B 0.00
Shionogi (SGIOY) Japan $13.819B 12.39
Neurocrine Biosciences (NBIX) United States $13.532B 56.19
United Therapeutics (UTHR) United States $11.005B 11.79
Catalent (CTLT) United States $10.120B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.712B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.896B 6.99
Revolution Medicines (RVMD) United States $6.131B 0.00
Ionis Pharmaceuticals (IONS) United States $6.062B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.847B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.317B 0.00
Summit Therapeutics (SMMT) United States $2.710B 0.00
Indivior (INDV) United States $2.424B 11.49
Corcept Therapeutics (CORT) United States $2.373B 24.00
PTC Therapeutics (PTCT) United States $2.191B 0.00
Dyne Therapeutics (DYN) United States $2.131B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.963B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.905B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.802B 10.67
Evotec AG (EVO) Germany $1.779B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.757B 18.16
Avadel Pharmaceuticals (AVDL) Ireland $1.613B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.90
Ardelyx (ARDX) United States $1.494B 0.00
Soleno Therapeutics (SLNO) United States $1.266B 0.00
Xencor (XNCR) United States $1.232B 0.00
Pacira BioSciences (PCRX) United States $1.225B 12.19
Ironwood Pharmaceuticals (IRWD) United States $1.224B 11.50
Collegium Pharmaceutical (COLL) United States $1.191B 7.33
4D Molecular Therapeutics (FDMT) United States $1.189B 0.00
Cronos Group (CRON) Canada $0.989B 0.00
Cassava Sciences (SAVA) United States $0.966B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.895B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
Relay Therapeutics (RLAY) United States $0.843B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Sage Therapeutics (SAGE) United States $0.824B 0.00
ARS Pharmaceuticals (SPRY) United States $0.806B 0.00
Enliven Therapeutics (ELVN) United States $0.804B 0.00
Ocular Therapeutix (OCUL) United States $0.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
Siga Technologies (SIGA) United States $0.625B 9.25
Savara (SVRA) United States $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.581B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.525B 0.00
Verve Therapeutics (VERV) United States $0.515B 0.00
Altimmune (ALT) United States $0.515B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Exscientia (EXAI) United Kingdom $0.487B 0.00
ProKidney (PROK) United States $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.455B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.443B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Larimar Therapeutics (LRMR) United States $0.411B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Harrow (HROW) United States $0.372B 0.00
Heron Therapeutics (HRTX) United States $0.368B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.53
Corbus Pharmaceuticals Holdings (CRBP) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.360B 0.00
Fractyl Health (GUTS) United States $0.321B 0.00
Bioventus (BVS) United States $0.315B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Black Diamond Therapeutics (BDTX) United States $0.309B 0.00
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.282B 0.00
Lyra Therapeutics (LYRA) United States $0.282B 0.00
Akebia Therapeutics (AKBA) United States $0.281B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.269B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Conduit Pharmaceuticals (CDT) United States $0.234B 0.00
Foghorn Therapeutics (FHTX) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Prelude Therapeutics (PRLD) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
Century Therapeutics (IPSC) United States $0.187B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
Achieve Life Sciences (ACHV) Canada $0.158B 0.00
CytoDyn (CYDY) United States $0.142B 0.00
Elite Pharmaceuticals (ELTP) United States $0.142B 13.25
Incannex Healthcare (IXHL) Australia $0.141B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.120B 2.51
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Eliem Therapeutics (ELYM) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.106B 0.00
GlycoMimetics (GLYC) United States $0.106B 0.00
Inotiv (NOTV) United States $0.104B 0.00
FibroGen (FGEN) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 6.37
Tempest Therapeutics (TPST) United States $0.079B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
JanOne (JAN) United States $0.044B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
DURECT (DRRX) United States $0.029B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 11.73
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.42